GuruFocus Premium Membership

Serving Intelligent Investors since 2004. Only 96 cents a day.

Free Trial

Free 7-day Trial
All Articles and Columns »

Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 22,222 Shares

January 12, 2010 | About:

insider

56 followers
President and CEO of Synta Pharmaceuticals Inc. (SNTA) Safi R Bahcall buys 22,222 shares of SNTA on 01/08/2010 at an average price of $4.5 a share.

Synta Pharmaceuticals Inc. has a market cap of $152.2 million; its shares were traded at around $4.48 with a P/E ratio of 2.5 and P/S ratio of 58.2.

This is the annual revenues and earnings per share of SNTA over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of SNTA.


CEO Recent Trades:



  • Buy:: President and CEO Safi R Bahcall bought 20,000 shares of SNTA stock on 08/06/2009 at the average price of 2.85, the price of the stock has increased by 57.19% since.



This is the insider trade history vs. stock price of SNTA. For the complete insider trading history of SNTA, click here.




Directors and Officers Recent Trades:



  • Buy:: Sr. VP, Drug Development Keizo Koya bought 10,000 shares of SNTA stock on 08/24/2009 at the average price of 2.84, the price of the stock has increased by 57.75% since.
  • Buy:: 10% Owner Lin Huey Chen bought 20,000 shares of SNTA stock on 08/06/2009 at the average price of 2.88, the price of the stock has increased by 55.56% since.
  • Buy:: Director, 10% Owner Lan Bo Chen bought 20,000 shares of SNTA stock on 08/06/2009 at the average price of 2.88, the price of the stock has increased by 55.56% since.


About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 4.3/5 (7 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide